Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | GCK | P35557 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26206444 | 0.90 | PTGER1 (0.36) | PTGER1GAAKDM4EALDH1A1HPGD | |
| SCHEMBL26205873 | 0.87 | MAPT (0.37) | PTGER1GAAKDM4EALDH1A1HPGD | |
| SCHEMBL27015244 | 0.83 | ADRB2 (0.37) | — | |
| SCHEMBL23833042 | 0.82 | — | — | |
| SCHEMBL23833040 | 0.81 | AAK1 (0.42) | PTGER1ALDH1A1HPGD | |
| SCHEMBL23833159 | 0.81 | AAK1 (0.42) | PTGER1ALDH1A1HPGD | |
| SCHEMBL27015257 | 0.80 | ADRB2 (0.39) | — | |
| SCHEMBL27015309 | 0.79 | PTGER1 (0.34) | PTGER1GAAKDM4EALDH1A1 | |
| SCHEMBL22526501 | 0.78 | ALDH1A1 (0.33) | KDM4EALDH1A1 | |
| SCHEMBL26206385 | 0.78 | FOS (0.36) | PTGER1KDM4EALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240016942-A1 | STAT DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240016942-A1 | STAT DEGRADERS AND USES THEREOF | STAT4, STAT1, STAT3 | PTGER1 2776/4885GCK 2181/4885GAA 312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.